Actively Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Led by Pfizer · Updated on 2026-05-14
80
Participants Needed
28
Research Sites
437 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.
CONDITIONS
Official Title
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must agree to follow the reproductive criteria as outlined in the protocol
- Participants have completed a qualifying Parent Study
- Participants were still receiving elranatamab when the Parent Study ended or completed
- Participants are currently deriving clinical benefit from elranatamab as judged by the investigator
You will not qualify if you...
- Any medical or psychiatric condition, including recent or active suicidal ideation or behavior, that increases risk or makes study participation inappropriate
- Participants who have not enrolled in or who discontinued elranatamab treatment in a Parent Study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 28 locations
1
UCHealth Poudre Valley Hospital
Fort Collins, Colorado, United States, 80524
Actively Recruiting
2
UCHealth Harmony
Fort Collins, Colorado, United States, 80528
Actively Recruiting
3
UCHealth Greeley Hospital
Greeley, Colorado, United States, 80634
Actively Recruiting
4
Longs Peak Hospital
Longmont, Colorado, United States, 80504
Actively Recruiting
5
UCHealth Longs Peak Medical Center
Longmont, Colorado, United States, 80504
Actively Recruiting
6
UCHealth - Medical Center of the Rockies
Loveland, Colorado, United States, 80538
Actively Recruiting
7
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
Coral Gables, Florida, United States, 33146
Actively Recruiting
8
University of Miami Hospital and Clinics Deerfield Beach
Deerfield Beach, Florida, United States, 33442
Actively Recruiting
9
Sylvester Comprehensive Cancer Center
Miami, Florida, United States, 33136
Actively Recruiting
10
University of Miami Hospital and Clinics - Griffin Cancer Research Building
Miami, Florida, United States, 33136
Actively Recruiting
11
University of Miami Hospital and Clinics
Miami, Florida, United States, 33136
Actively Recruiting
12
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
13
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)
Detroit, Michigan, United States, 48202
Actively Recruiting
14
St. David's South Austin Medical Center
Austin, Texas, United States, 78704
Actively Recruiting
15
Epworth Freemasons
Melbourne, Victoria, Australia, 3002
Not Yet Recruiting
16
Epworth Hospital
Richmond, Victoria, Australia, 3121
Not Yet Recruiting
17
Slade Pharmacy
Richmond, Victoria, Australia, 3121
Not Yet Recruiting
18
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, Canada, T2N 5GN
Actively Recruiting
19
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Actively Recruiting
20
McGill University Health Centre
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
21
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Active, Not Recruiting
22
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510555
Active, Not Recruiting
23
Shandong Provincial Hospital
Jinan, Shandong, China, 250021
Actively Recruiting
24
The first Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310003
Actively Recruiting
25
Japanese Red Cross Medical Center
Shibuya-ku, Tokyo, Japan, 150-8935
Actively Recruiting
26
University Hospital,Kyoto Prefectural University of Medicine
Kyoto, Japan, 602-8566
Actively Recruiting
27
National Taiwan University Hospital
Taipei, Taiwan, 10002
Actively Recruiting
28
Taipei Veterans General Hospital
Taipei, Taiwan, 11217
Actively Recruiting
Research Team
P
Pfizer CT.gov Call Center
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here